Skip to main content
. 2011 Feb 23;4(1):10–16. doi: 10.1111/j.1752-8062.2010.00253.x

Table 2.

Distribution of randomization assignments among samples of patients with STEMI.

Strategy Decision rule Circumstance 1: PCI* at 90 minutes vs. TT** at 30 minutes Circumstance 2: PCI* at 120 minutes vs. TT** at 30 minutes Circumstance 3: PCI* at 180 minutes vs. TT** at 15 minutes
Full sample (n = 2,781)
Use 50% PI for δ for patient* 50% PI < 0, treat w/TT** 0% 0% 22%
50% PI contains 0%, randomize 60% 93% 78%
50% PI > 0, treat w/PCI** 40% 7% 0%
Total 100% Total 100% Total 100%
RR > 1.2 in favor of either treatment$ TT predicted to be at least 20% better, treat with TT 0% 0% 25%
Neither has ≥20% predicted benefit, randomize 66% 100% 74%
PCI predicted to be at least 20% better, treat with PCI 34% 0% <1%
Total 100% Total 100% Total 100%
Subset of patients from TPI trial (n = 1,037)
Use 50% PI for δ for patient 50% PI < 0, treat w/TT 0% 0% 18%
50% PI contains 0%, randomize 62% 92% 82%
50% PI > 0, treat w/PCI 38% 8% 0%
Total 100% Total 100% Total 100%
RR > 1.2 in favor of either treatment TT predicted to be at least 20% better, treat with TT 0% 0% 20%
Neither has ≥20% predicted benefit, randomize 70% 100% 79%
PCI predicted to be at least 20% better, treat with PCI 30% 0% <1%
Total 100% Total 100% Total 100%

*50% prediction interval (PI) for delta (d), where delta = predicted (PCI) survival benefit = p(live) with PCI minus p(live) with TT.

**PCI, percutaneous coronary intervention (angioplasty); TT, thrombolytic therapy.This is the relative risk (RR) of death with treatment of TT versus PCI. This estimate is based on the PCI–TPI model predictions with the published model alone. It does not use results of the 1,000 simulations. A RR > 1.2 (for PCI vs. TT or TT vs. PCI) indicates that the predicted mortality at least 20% higher for one treatment versus the other.